These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Second-look laparotomy after chemotherapy in the management of ovarian malignancy. Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706 [TBL] [Abstract][Full Text] [Related]
30. Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma. Macrie BD; Strauss JB; Helenowski IB; Rademaker A; Schink JC; Lurain JR; Small W Int J Gynecol Cancer; 2014 Nov; 24(9):1597-602. PubMed ID: 25275661 [TBL] [Abstract][Full Text] [Related]
31. [Analysis of treatment and prognosis of recurrent epithelial ovarian carcinoma]. Yuan GW; Wu LY; Yao HW; Hou JL; Li XG; Liu LY Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):710-3. PubMed ID: 20021871 [TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies. Kunos C; Chen W; DeBernardo R; Waggoner S; Brindle J; Zhang Y; Williams J; Einstein D Technol Cancer Res Treat; 2009 Oct; 8(5):393-400. PubMed ID: 19754216 [TBL] [Abstract][Full Text] [Related]
33. Salvage radiotherapy for carcinoma of the ovary following chemotherapy. Cheung AY Gynecol Oncol; 1988 May; 30(1):15-20. PubMed ID: 3366392 [TBL] [Abstract][Full Text] [Related]
34. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer. Dinniwell R; Lock M; Pintilie M; Fyles A; Laframboise S; Depetrillo D; Levin W; Manchul L; Murphy J; Oza A; Rosen B; Sturgeon J; Milosevic M Int J Radiat Oncol Biol Phys; 2005 May; 62(1):104-10. PubMed ID: 15850909 [TBL] [Abstract][Full Text] [Related]
35. Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma. Haie C; Pejovic-Lenfant MH; George M; Michel G; Gerbaulet A; Prade M; Chassagne D Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):15-9. PubMed ID: 2745190 [TBL] [Abstract][Full Text] [Related]
36. Whole-abdomen radiation as a second-line therapy for epithelial ovarian cancer. Hoffman MS; Greenberg H; Finan M; Roberts WS; LaPolla JP; Praphat H; Cavanagh D Gynecol Oncol; 1989 Oct; 35(1):73-4. PubMed ID: 2792906 [TBL] [Abstract][Full Text] [Related]
37. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past? Skirnisdottir I; Nordqvist S; Sorbe B Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740 [TBL] [Abstract][Full Text] [Related]
38. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Whelan TJ; Dembo AJ; Bush RS; Sturgeon JF; Fine S; Pringle JF; Rawlings GA; Thomas GM; Simm J Int J Radiat Oncol Biol Phys; 1992; 22(5):853-8. PubMed ID: 1555976 [TBL] [Abstract][Full Text] [Related]
39. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543 [TBL] [Abstract][Full Text] [Related]